No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
3,000 (estimated)
Sponsor
University Hospital, Strasbourg, France · Other
Who this trial is looking for
This trial is looking for adults with chronic kidney disease to help understand their condition better. Participants will provide their medical data to improve CKD management before severe stages are reached.
Are You a Good Fit for This Trial?
You may be able to join if
I am 18 years or older
I have chronic kidney disease with GFR less than 30 ml/min/1.73 m2
I agree to allow my medical data to be used for this research
You may not be able to join if
I have expressed my opposition to participate in the study
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Chronic kidney disease (CKD) is a public health problem and affects about 10% of the world's adult population with a constantly increasing incidence. The approach to CKD in France is centered on access to replacement therapy (dialysis, renal transplantation), the cost of which amounts to 4 billion euros (data from the REIN registry).
Real-life data are essential to specify the characteristics of …
Chronic kidney disease (CKD) is a public health problem and affects about 10% of the world's adult population with a constantly increasing incidence. The approach to CKD in France is centered on access to replacement therapy (dialysis, renal transplantation), the cost of which amounts to 4 billion euros (data from the REIN registry).
Real-life data are essential to specify the characteristics of patients with chronic kidney disease and the factors associated with the evolution of CKD and the occurrence of complications in order to improve the management of CKD before the suppletion stage.
Since October 2019, CKD at the severe stage (stage 4) and at the non-dialysis end stage (stage 5) is subject to an annual flat fee (Article L. 162-22-6-2 of the Social Security Code). The reimbursement of these lump sums by the health insurance is subject to the collection and transmission of certain medical data by the establishments.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion criteria:
* Major subject (≥18 years)
* Subject included in the MRC package (GFR \<30 ml/min/1.73 m2)
* Subject who has not expressed opposition, after information, to the reuse of his or her data for the purpose of this research
Exclusion criteria:
\- Subject having expressed his oppos…
Inclusion criteria:
* Major subject (≥18 years)
* Subject included in the MRC package (GFR \<30 ml/min/1.73 m2)
* Subject who has not expressed opposition, after information, to the reuse of his or her data for the purpose of this research
Exclusion criteria:
\- Subject having expressed his opposition to participate in the study
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.